PapersPMID:42337792
Meta-analysis of the effects of ginger supplementation on glycemic control, blood pressure and lipid profile in patients with type 2 diabetes.
- findings
- 8
- compound
- 1
- endpoints
- 8
- no difference found
- 4
- Study, every finding
- meta-analysis
- Dose studied, every finding
- 1200 to 3000 mg/day, 8 to 12 weeks across trials
What moved
How to read these marks →“Pooling data from 4 clinical trials, the model indicated that ginger significantly reduced systolic blood pressure (MD = −1.62 mmHg, 95% CI (−3.01, −0.24), I2 = 6.09%, τ2 = 0.44, and Cochran’s Q: 3.29), but not diastolic blood pressure (MD = −2.41 mmHg, 95% CI (−5.45, 0.64), I2 = 76.40%, τ2 = 6.07, and Cochran’s Q: 12.71).”
- Effect
- −1.62 mean difference, 95% CI −3.01 to −0.24
- Population
- Patients with type 2 diabetes in placebo-controlled randomized trials of ginger (pooled from 4 trials)
“The model indicated that ginger significantly decreased FBS (MD = −16.27 mg/dL, 95% CI (−25.75, −6.80), I2 = 86.39%, τ2 = 158.79, and Cochran’s Q: 66.11), HbA1c (MD = −0.41%, 95% CI (−0.63, −0.20), I2 = 92.09%, τ2 = 0.06, and Cochran’s Q: 113.8), but its effects on HOMAIR did not reach the threshold of statistical significance (MD = −0.37%, 95% CI (−0.78, 0.03), I2 = 76.35%, τ2 = 0.13, and Cochran’s Q: 21.14).”
- Decreases fasting blood glucose
moderate
- Effect
- −16.27 mean difference, 95% CI −25.75 to −6.8
- Population
- Patients with type 2 diabetes in placebo-controlled randomized trials of ginger (13 trials in the review)
- Effect
- −0.41 mean difference, 95% CI −0.63 to −0.2
- Population
- Patients with type 2 diabetes in placebo-controlled randomized trials of ginger (13 trials in the review)
- Increases HDL cholesterol
moderate
“Regarding lipid profile, ginger significantly decreased triglyceride level (MD = −17.10 mg/dL, 95% CI (−31.13, −3.07), I2 = 81.61%, τ2 = 334.97, and Cochran’s Q: 48.94) and increased HDL-C level (MD = 2.13 mg/dL, 95% CI (0.44, 3.82), I2 = 85.72%, τ2 = 4.35, and Cochran’s Q: 70.03).”
- Effect
- 2.13 mean difference, 95% CI 0.44 to 3.82
- Population
- Patients with type 2 diabetes in placebo-controlled randomized trials of ginger (13 trials in the review)
What did not
“However, treatment with ginger did not change total cholesterol level (MD = −4.78 mg/dL, 95% CI (−15.27, 5.70), I2 = 92.45%, τ2 = 208.75, and Cochran’s Q: 119.21) and LDL-C level (MD = −5.36 mg/dL, 95% CI (−12.37, 1.65), I2 = 90.93%, τ2 = 99.72, and Cochran’s Q: 110.31).”
- Effect
- −5.36 mean difference, 95% CI −12.37 to 1.65
- Population
- Patients with type 2 diabetes in placebo-controlled randomized trials of ginger (13 trials in the review)
- Effect
- −4.78 mean difference, 95% CI −15.27 to 5.7
- Population
- Patients with type 2 diabetes in placebo-controlled randomized trials of ginger (13 trials in the review)
- Effect
- −2.41 mean difference, 95% CI −5.45 to 0.64
- Population
- Patients with type 2 diabetes in placebo-controlled randomized trials of ginger (pooled from 4 trials)
“Pooling data from 8 studies, the random-effects model showed that the beneficial effects of ginger on BMI did not meet the threshold of statistical significance (MD = −0.25 kg/m2, 95% CI (−0.52, 0.03), I2 = 83.05%, τ2 = 0.08, and Cochran’s Q: 41.31).”
- Effect
- −0.25 mean difference, 95% CI −0.52 to 0.03
- Population
- Patients with type 2 diabetes in placebo-controlled randomized trials of ginger (pooled from 8 studies)
Study record
- Design
- meta-analysis
- Species
- human
- Population
- Patients with type 2 diabetes
- Participants
- not reported
- Comparator
- placebo
- Duration
- not reported
- Endpoints measured
- 10